» Articles » PMID: 12741446

Validity of the General Practice Research Database

Overview
Journal Pharmacotherapy
Specialty Pharmacology
Date 2003 May 14
PMID 12741446
Citations 185
Authors
Affiliations
Soon will be listed here.
Abstract

The United Kingdom General Practice Research Database (GPRD) is an office-based, computer-generated, medical resource designed from its inception to be used for epidemiologic research. A distinct version of the GPRD is maintained by the Boston Collaborative Drug Surveillance Program and has been the source of more than 130 scientific articles primarily addressing drug safety issues. We reviewed evidence related to the validity of the GPRD. Specifically, with our extensive experience with this automated database, we evaluated the quality and completeness of the data that it contains.

Citing Articles

CO-19 PDB 2.0: A Comprehensive COVID-19 Database with Global Auto-Alerts, Statistical Analysis, and Cancer Correlations.

Ullah S, Li Y, Rahman W, Ullah F, Ijaz M, Ullah A Database (Oxford). 2024; 2024.

PMID: 39066515 PMC: 11281848. DOI: 10.1093/database/baae072.


Pooling of primary care electronic health record (EHR) data on Huntington's disease (HD) and cancer: establishing comparability of two large UK databases.

Dedman D, Williams R, Bhaskaran K, Douglas I BMJ Open. 2024; 14(2):e070258.

PMID: 38355188 PMC: 10868307. DOI: 10.1136/bmjopen-2022-070258.


Use of drugs for hyperlipidaemia and diabetes and risk of primary and secondary brain tumours: nested case-control studies using the UK Clinical Practice Research Datalink (CPRD).

Robinson J, Martin R, Ozawa M, Elwenspoek M, Redaniel M, Kurian K BMJ Open. 2024; 14(2):e072026.

PMID: 38336454 PMC: 10860117. DOI: 10.1136/bmjopen-2023-072026.


Presence of Breast Cancer Information Recorded in United Kingdom Primary Care Databases: Comparison of CPRD Aurum and CPRD GOLD (Companion Paper 1).

Hagberg K, Vasilakis-Scaramozza C, Persson R, Neasham D, Kafatos G, Jick S Clin Epidemiol. 2023; 15:1183-1192.

PMID: 38126005 PMC: 10731985. DOI: 10.2147/CLEP.S434795.


Dipeptidyl peptidase-4 inhibitors and the risk of skin cancer among patients with type 2 diabetes: a UK population-based cohort study.

Pradhan R, Yu O, Platt R, Azoulay L BMJ Open Diabetes Res Care. 2023; 11(6).

PMID: 37949470 PMC: 10649616. DOI: 10.1136/bmjdrc-2023-003550.